株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

世界のクローズドシステムドラッグトランスファーデバイス(CSTD)市場の予測

Global Closed System Drug Transfer Device (CSTD) Market Research Report Forecast to 2025

発行 Market Research Future 商品コード 888172
出版日 ページ情報 英文 110 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=109.53円で換算しております。
Back to Top
世界のクローズドシステムドラッグトランスファーデバイス(CSTD)市場の予測 Global Closed System Drug Transfer Device (CSTD) Market Research Report Forecast to 2025
出版日: 2019年06月30日 ページ情報: 英文 110 Pages
概要

当レポートでは、世界のクローズドシステムドラッグトランスファーデバイス(CSTD)市場について調査し、市場の動向とセグメント別動向、地域別予測、市場に参入する企業のプロファイルについてまとめています。

第1章 レポートのプロローグ

第2章 市場イントロダクション

第3章 調査方法

第4章 市場動向

  • イントロダクション
  • 促進因子
  • 阻害因子
  • 機会

第5章 市場因子分析

  • ポーターズファイブフォース分析
  • サプライチェーン分析
  • 投資の機会
  • 価格分析
  • マーケティングチャネル
  • 法務
  • 生産コスト分析

第6章 タイプ別市場

  • 概要

第7章 デリバリー別市場

  • 概要
    • イントロダクション
    • クローズドバッグ/ラインアクセスデバイス
    • クローズドバイアルアクセスデバイス
    • クローズドシリンジセーフティデバイス

第8章 エンドユーザー別市場

  • 概要
    • イントロダクション
    • 専門機関
    • 病院・クリニック

第9章 地域別市場

  • イントロダクション
  • 南北アメリカ
  • 欧州
  • アジア太平洋地域
  • 中東・アフリカ

第10章 企業動向

第11章 企業プロファイル

第12章 付録

図表

List of Tables

  • TABLE 1 PRIMARY INTERVIEWS
  • TABLE 2 GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY TYPE, 2015-2025 (USD MILLION)
  • TABLE 3 GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET FOR BARRIER-TYPE, BY REGION, 2015-2025 (USD MILLION)
  • TABLE 4 GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET FOR FILTRATION-TYPE, BY REGION, 2015-2025 (USD MILLION)
  • TABLE 5 GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY DELIVERY, 2015-2025 (USD MILLION)
  • TABLE 6 GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET FOR CLOSED BAG/LINE ACCESS DEVICES, BY REGION, 2015-2025 (USD MILLION)
  • TABLE 7 GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET FOR CLOSED VIAL ACCESS DEVICES, BY REGION, 2015-2025 (USD MILLION)
  • TABLE 8 GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET FOR CLOSED SYRINGE SAFETY DEVICES, BY REGION, 2015-2025 (USD MILLION)
  • TABLE 9 GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY END USER, 2015-2025 (USD MILLION)
  • TABLE 10 GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET FOR SPECIALTY CENTERS, BY REGION, 2015-2025 (USD MILLION)
  • TABLE 11 GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET FOR HOSPITALS & CLINICS, BY REGION, 2015-2025 (USD MILLION)
  • TABLE 12 GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY REGION, 2015-2025 (USD MILLION)
  • TABLE 13 AMERICAS: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY REGION, 2015-2025 (USD MILLION)
  • TABLE 14 AMERICAS: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY TYPE, 2015-2025 (USD MILLION)
  • TABLE 15 AMERICAS: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY DELIVERY, 2015-2025 (USD MILLION)
  • TABLE 16 AMERICAS: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY END USER 2015-2025 (USD MILLION)
  • TABLE 17 NORTH AMERICA: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY TYPE, 2015-2025 (USD MILLION)
  • TABLE 18 NORTH AMERICA: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY DELIVERY, 2015-2025 (USD MILLION)
  • TABLE 19 NORTH AMERICA: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY END USER 2015-2025 (USD MILLION)
  • TABLE 20 US: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY TYPE, 2015-2025 (USD MILLION)
  • TABLE 21 US: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY DELIVERY, 2015-2025 (USD MILLION)
  • TABLE 22 US: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY END USER 2015-2025 (USD MILLION)
  • TABLE 23 CANADA: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY TYPE, 2015-2025 (USD MILLION)
  • TABLE 24 CANADA: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY DELIVERY, 2015-2025 (USD MILLION)
  • TABLE 25 CANADA: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY END USER 2015-2025 (USD MILLION)
  • TABLE 26 MEXICO: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY TYPE, 2015-2025 (USD MILLION)
  • TABLE 27 MEXICO: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY DELIVERY, 2015-2025 (USD MILLION)
  • TABLE 28 MEXICO: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY END USER 2015-2025 (USD MILLION)
  • TABLE 29 SOUTH AMERICA: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY TYPE, 2015-2025 (USD MILLION)
  • TABLE 30 SOUTH AMERICA: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY DELIVERY, 2015-2025 (USD MILLION)
  • TABLE 31 SOUTH AMERICA: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY END USER 2015-2025 (USD MILLION)
  • TABLE 32 BRAZIL: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY TYPE, 2015-2025 (USD MILLION)
  • TABLE 33 BRAZIL: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY DELIVERY, 2015-2025 (USD MILLION)
  • TABLE 34 BRAZIL: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY END USER 2015-2025 (USD MILLION)
  • TABLE 35 REST OF SOUTH AMERICA: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY TYPE, 2015-2025 (USD MILLION)
  • TABLE 36 REST OF SOUTH AMERICA: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY DELIVERY, 2015-2025 (USD MILLION)
  • TABLE 37 REST OF SOUTH AMERICA: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY END USER 2015-2025 (USD MILLION)
  • TABLE 38 EUROPE: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY REGION, 2015-2025 (USD MILLION)
  • TABLE 39 EUROPE: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY TYPE, 2015-2025 (USD MILLION)
  • TABLE 40 EUROPE: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY DELIVERY, 2015-2025 (USD MILLION)
  • TABLE 41 EUROPE: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY END USER 2015-2025 (USD MILLION)
  • TABLE 42 WESTERN EUROPE: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY TYPE, 2015-2025 (USD MILLION)
  • TABLE 43 WESTERN EUROPE: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY DELIVERY, 2015-2025 (USD MILLION)
  • TABLE 44 WESTERN EUROPE: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY END USER 2015-2025 (USD MILLION)
  • TABLE 45 GERMANY: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY TYPE, 2015-2025 (USD MILLION)
  • TABLE 46 GERMANY: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY DELIVERY, 2015-2025 (USD MILLION)
  • TABLE 47 GERMANY: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY END USER 2015-2025 (USD MILLION)
  • TABLE 48 FRANCE: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY TYPE, 2015-2025 (USD MILLION)
  • TABLE 49 FRANCE: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY DELIVERY, 2015-2025 (USD MILLION)
  • TABLE 50 FRANCE: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY END USER 2015-2025 (USD MILLION)
  • TABLE 51 UK: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY TYPE, 2015-2025 (USD MILLION)
  • TABLE 52 UK: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY DELIVERY, 2015-2025 (USD MILLION)
  • TABLE 53 UK: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY END USER 2015-2025 (USD MILLION)
  • TABLE 54 ITALY: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY TYPE, 2015-2025 (USD MILLION)
  • TABLE 55 ITALY: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY DELIVERY, 2015-2025 (USD MILLION)
  • TABLE 56 ITALY: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY END USER 2015-2025 (USD MILLION)
  • TABLE 57 SPAIN: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY TYPE, 2015-2025 (USD MILLION)
  • TABLE 58 SPAIN: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY DELIVERY, 2015-2025 (USD MILLION)
  • TABLE 59 SPAIN: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY END USER 2015-2025 (USD MILLION)
  • TABLE 60 REST OF WESTERN EUROPE: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY TYPE, 2015-2025 (USD MILLION)
  • TABLE 61 REST OF WESTERN EUROPE: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY DELIVERY, 2015-2025 (USD MILLION)
  • TABLE 62 REST OF WESTERN EUROPE: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY END USER 2015-2025 (USD MILLION)
  • TABLE 63 EASTERN EUROPE: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY TYPE, 2015-2025 (USD MILLION)
  • TABLE 64 EASTERN EUROPE: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY DELIVERY, 2015-2025 (USD MILLION)
  • TABLE 65 EASTERN EUROPE: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY END USER 2015-2025 (USD MILLION)
  • TABLE 66 ASIA-PACIFIC: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY COUNTRY, 2015-2025 (USD MILLION)
  • TABLE 67 ASIA-PACIFIC: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY TYPE, 2015-2025 (USD MILLION)
  • TABLE 68 ASIA-PACIFIC: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY DELIVERY, 2015-2025 (USD MILLION)
  • TABLE 69 ASIA-PACIFIC: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY END USER 2015-2025 (USD MILLION)
  • TABLE 70 CHINA: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY TYPE, 2015-2025 (USD MILLION)
  • TABLE 71 CHINA: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY DELIVERY, 2015-2025 (USD MILLION)
  • TABLE 72 CHINA: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY END USER 2015-2025 (USD MILLION)
  • TABLE 73 INDIA: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY TYPE, 2015-2025 (USD MILLION)
  • TABLE 74 INDIA: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY DELIVERY, 2015-2025 (USD MILLION)
  • TABLE 75 INDIA: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY END USER 2015-2025 (USD MILLION)
  • TABLE 76 JAPAN: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY TYPE, 2015-2025 (USD MILLION)
  • TABLE 77 JAPAN: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY DELIVERY, 2015-2025 (USD MILLION)
  • TABLE 78 JAPAN: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY END USER 2015-2025 (USD MILLION)
  • TABLE 79 AUSTRALIA: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY TYPE, 2015-2025 (USD MILLION)
  • TABLE 80 AUSTRALIA: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY DELIVERY, 2015-2025 (USD MILLION)
  • TABLE 81 AUSTRALIA: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY END USER 2015-2025 (USD MILLION)
  • TABLE 82 SOUTH KOREA: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY TYPE, 2015-2025 (USD MILLION)
  • TABLE 83 SOUTH KOREA: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY DELIVERY, 2015-2025 (USD MILLION)
  • TABLE 84 SOUTH KOREA: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY END USER 2015-2025 (USD MILLION)
  • TABLE 85 INDONESIA: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY TYPE, 2015-2025 (USD MILLION)
  • TABLE 86 INDONESIA: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY DELIVERY, 2015-2025 (USD MILLION)
  • TABLE 87 INDONESIA: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY END USER 2015-2025 (USD MILLION)
  • TABLE 88 REST OF ASIA-PACIFIC: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY TYPE, 2015-2025 (USD MILLION)
  • TABLE 89 REST OF ASIA-PACIFIC: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY DELIVERY, 2015-2025 (USD MILLION)
  • TABLE 90 REST OF ASIA-PACIFIC: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY END USER 2015-2025 (USD MILLION)
  • TABLE 91 MIDDLE EAST AND AFRICA: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY REGION, 2015-2025 (USD MILLION)
  • TABLE 92 MIDDLE EAST AND AFRICA: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY TYPE, 2015-2025 (USD MILLION)
  • TABLE 93 MIDDLE EAST AND AFRICA: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY DELIVERY, 2015-2025 (USD MILLION)
  • TABLE 94 MIDDLE EAST AND AFRICA: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY END USER 2015-2025 (USD MILLION)
  • TABLE 95 MIDDLE EAST: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY TYPE, 2015-2025 (USD MILLION)
  • TABLE 96 MIDDLE EAST: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY DELIVERY, 2015-2025 (USD MILLION)
  • TABLE 97 MIDDLE EAST: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY END USER 2015-2025 (USD MILLION)
  • TABLE 98 AFRICA: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY TYPE, 2015-2025 (USD MILLION)
  • TABLE 99 AFRICA: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY DELIVERY, 2015-2025 (USD MILLION)
  • TABLE 100 AFRICA: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY END USER 2015-2025 (USD MILLION)
  • TABLE 101 MAJOR MANUFACTURERS IN THE GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET
  • TABLE 102 KEY DEVELOPMENTS BY PLAYERS IN THE MARKET

List of Figures

  • FIGURE 1 GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET: MARKET STRUCTURE
  • FIGURE 2 RESEARCH PROCESS
  • FIGURE 3 TOP-DOWN & BOTTOM-UP APPROACH
  • FIGURE 4 MARKET DYNAMICS: ANALYSIS OF THE GLOBAL CSTD MARKET
  • FIGURE 5 PORTER'S FIVE FORCES ANALYSIS OF THE GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET
  • FIGURE 6 SUPPLY CHAIN: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET
  • FIGURE 7 GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY TYPE, 2017 (% SHARE)
  • FIGURE 8 GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY TYPE, 2017 & 2025
  • FIGURE 9 GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY DELIVERY, 2017 (% SHARE)
  • FIGURE 10 GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY DELIVERY, 2017 & 2025
  • FIGURE 11 GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY END USER, 2017 (% SHARE)
  • FIGURE 12 GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY END USER, 2017 & 2025
  • FIGURE 13 GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY REGION, 2017 & 2025 (USD MILLION)
  • FIGURE 14 GLOBAL CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET, BY REGION, 2017 (% SHARE)
  • FIGURE 15 AMERICAS: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET SHARE, BY REGION, 2017
  • FIGURE 16 EUROPE: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET SHARE, BY REGION, 2017 (%)
  • FIGURE 17 WESTERN EUROPE: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET SHARE, BY COUNTRY, 2017 (%)
  • FIGURE 18 ASIA-PACIFIC: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET SHARE, BY COUNTRY, 2017 (%)
  • FIGURE 19 MIDDLE EAST AND AFRICA: CLOSED SYSTEM DRUG TRANSFER DEVICE (CSTD) MARKET SHARE, BY REGION, 2017 (%)
  • FIGURE 20 CATEGORY WISE SHARE OF KEY DEVELOPMENTS
目次

Introduction

Closed system drug transfer device (CSTD) prevents the transfer of environmental contaminants into the system and the release of hazardous drugs or vapor concentrations outside the system. The exposure of healthcare personnel such as pharmacists, technicians, and ancillary pharmacy staff to hazardous antineoplastic drugs (AHD), has been a great concern for several decades. Many AHDs are carcinogenic, and their prolonged exposure could lead to skin rashes, infertility, miscarriages, congenital disabilities, and possibly leukemia or other cancers. Organizations such as the National Institute for Occupational Safety and Health (NIOSH) and the United States Pharmacopeia have recommended the use of specialized IV equipment called CSTD along with personal protective equipment (PPE) such as gloves, masks, gowns, and biological safety cabinets to minimize the exposure of patients and clinicians to hazardous drugs. The global CSTD market is emerging due to the rising prevalence of cancer cases along with an increased risk of exposure to hazardous drugs for healthcare personnel and several safety guidelines and legislation for the use of CSTDs. However, high cost and adverse events and statutory warnings by the Food and Drug Administration (FDA) for the use of CSTDs are hampering the growth of the market.

The global closed system drug transfer device (CSTD) market has been segmented, by type, delivery, and end user.

Based on type, the global closed system drug transfer device (CSTD) market has been categorized as barrier-type and filtration-type.

Based on delivery, the global closed system drug transfer device (CSTD) market is further sub-segmented into closed bag/line access devices, closed vial access devices, and closed syringe safety devices.

Based on end user, the market has been classified as specialty centers and hospitals & clinics.

The global closed system drug transfer device (CSTD) market was valued at USD 1,523.81 million in 2017 and is expected to register a CAGR of 19.10% during the forecast period of 2018 to 2025.

Key Players

Some of the key players in the global closed system drug transfer device (CSTD) market are Becton, Dickinson and Company, Teva Pharmaceutical Industries Ltd, Equashield LLC, ICU Medical Inc, Yukon Medical, and Corvida Medical.

Objectives of the Study

  • To provide a detailed analysis of the market structure along with a forecast of various segments and sub-segments of the global closed system drug transfer device (CSTD) market
  • To provide insights into factors influencing and affecting market growth
  • To provide historical and forecast revenue of market segments and sub-segments with respect to countries
  • To provide strategic profiling of key players in the market and comprehensively analyzing their market share, core competencies, and drawing a competitive landscape for the market
  • To provide economic factors that influence the global closed system drug transfer device (CSTD) market
  • To provide a detailed analysis of the value chain and supply chain of the global closed system drug transfer device (CSTD) market

Target Audience

  • Research and Development (R&D) Companies
  • Academic Institutes and Universities
  • Pharmaceutical Companies
  • Raw Material Suppliers
  • Suppliers and Distributors
  • Government
  • Potential Investors

Key Findings

  • The global closed system drug transfer device (CSTD) market is expected to reach USD 6,312.52 million by 2025 at a CAGR of 19.10% from 2018 to 2025
  • Based on type, the barrier-type segment holds the largest market share and is expected to reach USD 5,526.38 million by 2025 at a CAGR of 19.69% from 2018 to 2025
  • The market in the Americas is expected to account for the largest share of the global closed system drug transfer device (CSTD) market and is projected to reach USD 2,880.78 million by 2025
  • The closed system drug transfer device (CSTD) market in Asia-Pacific is projected to be the fastest-growing at a CAGR of 20.97% from 2018 to 2025

Regional Analysis

  • Americas
    • North America
  • US
  • Canada
    • Latin America
  • Europe
    • Western Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Western Europe
    • Eastern Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • Middle East & Africa
    • Middle East
    • Africa

Table of Contents

1 Report Prologue

2 Market Introduction

  • 2.1 Introduction
  • 2.2 Assumptions & Limitations
    • 2.2.1 Assumptions
    • 2.2.2 Limitations
  • 2.3 Market Structure

3 Research Methodology

  • 3.1 Research Process
  • 3.2 Primary Research
  • 3.3 Secondary Research
  • 3.4 Market Size Estimation
  • 3.5 Forecast Model

4 Market Dynamics

  • 4.1 Introduction
  • 4.2 Drivers
    • 4.2.1 Rising prevalence of cancer cases
    • 4.2.2 Increased risk of exposure to hazardous drugs for healthcare personnel
    • 4.2.3 Several safety guidelines and legislation for the use of CSTD
  • 4.3 Restraints
    • 4.3.1 High cost
    • 4.3.2 Adverse events and statutory warning by FDA for the use of CSTD
  • 4.4 Opportunity
    • 4.4.1 Emerging markets of CSTD

5 Market Factor Analysis

  • 5.1 Porter's Five Forces Analysis
    • 5.1.1 Bargaining Power of Suppliers
    • 5.1.2 Bargaining Power of Buyers
    • 5.1.3 Threat of New Entrants
    • 5.1.4 Threat of Substitutes
    • 5.1.5 Intensity of Rivalry
  • 5.2 Supply Chain Analysis
    • 5.2.1 R&D
    • 5.2.2 Manufacturing
    • 5.2.3 Distribution
    • 5.2.4 Marketing & Sales
    • 5.2.5 Post-Sales Monitoring
  • 5.3 Investment Opportunities
  • 5.4 Pricing Analysis
  • 5.5 Marketing Channel
    • 5.5.1 Direct Marketing
    • 5.5.2 Indirect Marketing
  • 5.6 Regulatory Affairs
  • 5.7 Cost of Production Analysis
    • 5.7.1 Raw Material Cost Analysis
    • 5.7.2 Technology Cost Analysis
    • 5.7.3 Labor Cost Analysis

6 Global Closed System Drug Transfer Device (CSTD) Market, by Type

  • 6.1 Overview
    • 6.1.1 Introduction
    • 6.1.2 Barrier-Type
    • 6.1.3 Filtration-Type

7 Global Closed System Drug Transfer Device (CSTD) Market, by Delivery

  • 7.1 Overview
    • 7.1.1 Introduction
    • 7.1.2 Closed Bag/Line Access Devices
    • 7.1.3 Closed Vial Access Devices
    • 7.1.4 Closed Syringe Safety Devices

8 Global Closed System Drug Transfer Device (CSTD) Market, by End User

  • 8.1 Overview
    • 8.1.1 Introduction
    • 8.1.2 Specialty Centers
    • 8.1.3 Hospitals & Clinics

9 Global Closed System Drug Transfer Device (CSTD) Market, by Region

  • 9.1 Introduction
  • 9.2 Americas
    • 9.2.1 North America
      • 9.2.1.1 US
      • 9.2.1.2 Canada
      • 9.2.1.3 Mexico
    • 9.2.2 South America
      • 9.2.2.1 Brazil
      • 9.2.2.2 Rest of South America
  • 9.3 Europe
    • 9.3.1 Western Europe
      • 9.3.1.1 Germany
      • 9.3.1.2 France
      • 9.3.1.3 UK
      • 9.3.1.4 Italy
      • 9.3.1.5 Spain
      • 9.3.1.6 Rest of Western Europe
    • 9.3.2 Eastern Europe
  • 9.4 Asia-Pacific
    • 9.4.1 China
    • 9.4.2 India
    • 9.4.3 Japan
    • 9.4.4 Australia
    • 9.4.5 South Korea
    • 9.4.6 Indonesia
    • 9.4.7 Rest of Asia-Pacific
  • 9.5 Middle East and Africa
    • 9.5.1 Middle East
    • 9.5.2 Africa

10 Competitive Landscape

  • 10.1 Introduction
  • 10.2 Key developments

11 Company Profile

  • 11.1 Becton, Dickinson and Company
    • 11.1.1 Company Overview
    • 11.1.2 Financial Overview
    • 11.1.3 Products/Services Offered
    • 11.1.4 Key Developments
    • 11.1.5 SWOT Analysis
    • 11.1.6 Key Strategies
  • 11.2 Teva Pharmaceutical Industries Ltd
    • 11.2.1 Company Overview
    • 11.2.2 Financial Overview
    • 11.2.3 Products/Services Offered
    • 11.2.4 Key Developments
    • 11.2.5 SWOT Analysis
    • 11.2.6 Key Strategies
  • 11.3 Equashield LLC
    • 11.3.1 Company Overview
    • 11.3.2 Financial Overview
    • 11.3.3 Products/Services Offered
    • 11.3.4 Key Developments
    • 11.3.5 SWOT Analysis
    • 11.3.6 Key Strategies
  • 11.4 ICU Medical Inc
    • 11.4.1 Company Overview
    • 11.4.2 Financial Overview
    • 11.4.3 Products/Services Offered
    • 11.4.4 SWOT Analysis
    • 11.4.5 Key Developments
    • 11.4.6 Key Strategies
  • 11.5 Yukon Medical
    • 11.5.1 Company Overview
    • 11.5.2 Financial Overview
    • 11.5.3 Products/Services Offered
    • 11.5.4 SWOT Analysis
    • 11.5.5 Key Developments
    • 11.5.6 Key Strategies
  • 11.6 Corvida Medical
    • 11.6.1 Company Overview
    • 11.6.2 Financial Overview
    • 11.6.3 Products/Services Offered
    • 11.6.4 Key Developments
    • 11.6.5 SWOT Analysis
    • 11.6.6 Key Strategies

12 Appendix

  • 12.1 Discussion Blue Print
Back to Top